1
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Antimicrobial-impregnated catheters for reducing nosocomial catheter-associated blood stream infections in the pediatric intensive care unit

, , , &
Pages 33-40 | Published online: 04 Dec 2011

References

  • Edgeworth JD, Treacher DF, Eykyn SJ. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999;27: 1421–8.
  • Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori T, Banerjee S, Tolson J, Henderson T, Gaynes RP, Martone WJ, and The National Nosocomial Infections Surveillance System. Nosocomial Infection Rates in Adult and Pediatric Intensive Care Units in the United States. Am J Med 1991;91(Suppl. 3B):185–191.
  • Maki DG. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention, and management. In Bisno AT, Waldvogel FA, editors. Infections associated with indwelling medical devices, 2nd ed. Washington, DC: ASM Press; 1994. pp 155–205.
  • Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991;100:164–7.
  • Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–601.
  • Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, Valles J. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027–30.
  • DiGiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial blood-stream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976–81.
  • Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related blood stream infection by useof an antiseptic-impregnated catheter. A randomized con-trolled trial. Ann Intern Med 1997;127:257–66.
  • Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, and the Texas Medical Center Catheter Study Group. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and blood stream infections. A randomized, double-blind trial. Ann Intern Med 1997;127:267–74.
  • Veenstra DL, Saint S, Somnath S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis. JANIA 1999;261–7.
  • Mann MG, Lee JC, Skurnick JH. Prevention of nosocomial bloodstream infections: Effectiveness of antimicrobial-im-pregnated and heparin-bonded central venous catheters. Crit Care Med 2000;28:3332–8.
  • Hanley EM, Veeder A, Smith T, Drusano G, Currie E, Venezia RA. Evaluation of an antiseptic triple-lumen catheter in an intensive care unit. Crit Care Med 2000;28:366–70.
  • Kamal GD, Pfaller MA, Rempe LE, Jebson PJR Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JANIA 1991;265: 2364–8.
  • Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, for the Catheter Study Group. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999;340:1–8.
  • Hanna HA, Raad II, Hackett B, Wallace SK, Price KJ, Coyle DE, et al., and the MD Anderson Catheter Study Group. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest 2003;124:1030–8.
  • Brun-Buisson C, Doyon F, Sollet J-P, Cochard J-F, Cohen Y, Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: A randomized controlled trial. Intensive Care Med 2004;30:837–43.
  • Ciresi DL, Albrecht RNI, Volkers PA, Scholten DJ. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996;62:641–6.
  • Pemberton BL, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E. No difference in catheter sepsis between standard and antiseptic central venous catheters. Arch Surg 1996;131: 986–9.
  • Leon C, Ruiz-Santana S, Rello J, de la Torre MV, Valles J, Alvarez-Lerma F, et al. for the Cabana Study Group. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, con-trolled, multicenter trial. Intensive Care Med 2004;1891–9.
  • Logghe C, Van Ossel C, D'Hoore W, Ezzedine H, Wauters G, Haxhe JJ. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infections in leukaemic patients: a randomized controlled trial. J Hosp Infect 1997;37:145–56.
  • Loo S, Heerden PV Van, Gollege CL, Roberts BL, Power BM. Infection in central lines: antiseptic-impregnated cathe-ter vs. standard non-impregnated catheters. Anaesth Intensive Care 1997;25:637–9.
  • Heard SO, Wagle M, Vijayakumar E, McLean S, Bruegge-mann A, Napolitano L, et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfa-diazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998;158:81–7.
  • Richards MJ, Edwards JR, Culver DH, Gaynes RP, and the National Nosocomial Infections Surveillance System. Noso-comial infections in pediatric intensive care units in theUnited States. Pediatrics 1999;103(4). Available from: URL: http://www.pediatrics.orgicgi/content/full/103/4/e39.
  • Richards MJ, Edwards JR, Culver DH, Gaynes RR The National Nosocomial Infections Surveillance System. Noso-comial infections in medical intensive care units in the United States. Crit Care Med 1999;27:887–92.
  • O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51:1–29.
  • Mrowczynski W, Wojtalik M, Zawadzka D, Sharma G, Henschke J, Bartkowski R, Pawelec-Wojtalik M, Wodzinski A, Westerski P. Infection risk factors in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2002;10:329–33.
  • Levy I, Ovadia B, Erez E, Rinat S, Ashkenazi S, Birk E, Konisberger H, Vidne B, Dagan 0. Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. J Hosp Infect 2003;53: 111–16.
  • Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated pediatric risk of mortality score. Crit Care Med 1996;24:743–52.
  • Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339–43.
  • Odetola FO, Moler FW, Dechert RE, VanDerElzen K, Chenoweth C. Nosocomial catheter-related bloodstream infections in a pediatric intensive care unit: risk and rates associated with various intravascular technologies. Pediatr Crit Care Med 2003;4:432–6.
  • Yogaraj JS, Elward AM, Fraser VJ. Rate, risk factors, and outcomes of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2002;110: 481–5.
  • Singh-Naz N, Sprague BM, Patel KM, Pollack MM. Risk assessment and standardized nosocomial infection rate in critically ill children. Crit Care Med 2000;28:2069–75.
  • Pinilla JC, Ross DF, Martin T, Crump H. Study of the incidence of intravascular catheter infection and associated septicemia in critically ill patients. Crit Care Med 1983;11: 21–5.
  • Moro ML, Vigano EF, Lepri AC. The central venous catheter-related infections study group. Infect Control Hosp Epidemiol 1994;15:253–64.
  • Norwood S, Jenkins G. An evaluation of triple-lumen catheter infections using a guidewire exchange technique. J Trauma 1990;30:706–12.
  • Ullman RE, Gurevich I, Schoch PE, Cunha BA. Colonization and bacteremia related to duration of triple-lumen intravas-cular catheter placement. Am J Infect Control 1990;18:201–7.
  • Raad I, Costerton JW, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colo-nization and duration of placement. J Infect Dis 1993;168: 400–7.
  • Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 2002;34:1232–42.
  • Carrasco MN, Bueno A, de las Cuevas C, Jimenez S, Salinas I, Sartorius A, et al. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Med 2004;30:633–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.